Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dexamethasone in hyperleukocytic acute myeloid leukemia.

Haematologica - 1 Jun 2018

Bertoli Sarah, Picard Muriel, Bérard Emilie, Griessinger Emmanuel, Larrue Clément, Mouchel Pierre Luc, Vergez François, Tavitian Suzanne, Yon Edwige, Ruiz Jean, Delabesse Eric, Luquet Isabelle, Linares Laetitia Karine, Saland Estelle, Carroll Martin, Danet-Desnoyers Gwenn, Sarry Audrey, Huguet Françoise, Sarry Jean Emmanuel, Récher Christian

Abstract excerpt

Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation contribute to leukostasis and chemoresistance, dexamethasone added to chemotherapy could improve outcomes. This retrospective study evaluated the impact of adding or not adding dexamethasone to chemotherapy in a cohort of 160 patients with at least 50×109 white...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Dexamethasone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Kaplan-Meier Estimate

Share to Leukocytosis

Share to Nucleophosmin

Share to Recurrence

Share to Remission Induction

Source

Open in PubMed Open full text

Identifiers

PMID: 29519869
DOI: 10.3324/haematol.2017.184267
PMCID: PMC6058767

Genes

NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dexamethasone in hyperleukocytic acute myeloid leukemia.PMID 29519869Read ↗

Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic dataSemantic proximity Read ↗

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AMLSemantic proximity Read ↗

Vitamin C and D supplementation in acute myeloid leukemia.Semantic proximity Read ↗

Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion.Semantic proximity Read ↗

Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines.Semantic proximity Read ↗

Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.Semantic proximity Read ↗

Establishment of a Novel CD34+ Hematopoietic Stem Cell-derived Xenograft Model of Hyperleukocytic Acute Myeloid LeukemiaSemantic proximity Read ↗

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial resultsSemantic proximity Read ↗

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myelomaSemantic proximity Read ↗

Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

Glucocorticoid Sensitivity Among Young Survivors of Childhood Acute Lymphoblastic Leukemia: What Does It Matter?Semantic proximity Read ↗

A map of gene expression in neutrophil-like cell linesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.